← FDA Drug Approvals (Drugs@FDA)
LATANOPROSTENE BUNOD
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2025-04-29
Drug application
- FDA Application #
ANDA217387- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LATANOPROSTENE BUNOD
- Generic name
- LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024%
- Active ingredients
- LATANOPROSTENE BUNOD
- Dosage form
- SOLUTION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- Prescription
- Sponsor
- GLAND
- Manufacturer
- Gland Pharma Limited
- First approval
- 2025-04-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown